The Current Ratio as of December 2024 (TTM) for Ionis Pharmaceuticals, Inc. (IONS) is 8.91

According to Ionis Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.91. This represents a change of 19.65% compared to the average of 7.45 of the last 4 quarters.

Ionis Pharmaceuticals, Inc. (IONS) Historical Current Ratio (quarterly & annually)

How has IONS Current Ratio performed in the past?

The mean historical Current Ratio of Ionis Pharmaceuticals, Inc. over the last ten years is 7.19. The current 8.91 Current Ratio has changed 12.29% with respect to the historical average. Over the past ten years (40 quarters), IONS's Current Ratio was at its highest in in the June 2020 quarter at 10.94. The Current Ratio was at its lowest in in the September 2023 quarter at 2.82.

Ionis Pharmaceuticals, Inc. (IONS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ionis Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ionis Pharmaceuticals, Inc. (IONS) Average Current Ratio

How has IONS Current Ratio performed in the past?

The current Current Ratio of Ionis Pharmaceuticals, Inc. (IONS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ionis Pharmaceuticals, Inc. (IONS) Current Ratio vs. Peers

How is IONS’s Current Ratio compared to its peers?

Ionis Pharmaceuticals, Inc.’s Current Ratio is less than Arrowhead Pharmaceuticals, Inc. (0), greater than BioMarin Pharmaceutical Inc. (6.74), greater than Incyte Corporation (4.27), greater than Apellis Pharmaceuticals, Inc. (1.87), greater than Viking Therapeutics, Inc. (4.36), less than Intercept Pharmaceuticals, Inc. (36.47), greater than Terns Pharmaceuticals, Inc. (4.22), less than Akero Therapeutics, Inc. (32.99), less than Reata Pharmaceuticals, Inc. (17.25), greater than Seagen Inc. (6.75), greater than Alnylam Pharmaceuticals, Inc. (2.67), greater than Exelixis, Inc. (2.75), greater than Halozyme Therapeutics, Inc. (3.93), less than PTC Therapeutics, Inc. (10.36), greater than Krystal Biotech, Inc. (2.10), greater than Sarepta Therapeutics, Inc. (7.97), greater than Iovance Biotherapeutics, Inc. (3.84), greater than Madrigal Pharmaceuticals, Inc. (4.22), greater than null (5.98),

Build a custom stock screener for Ionis Pharmaceuticals, Inc. (IONS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ionis Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ionis Pharmaceuticals, Inc. (IONS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ionis Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.